State of Tennessee, Department of Treasury’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32M Buy
41,458
+1,322
+3% +$1.01M 0.11% 179
2025
Q4
$29.8M Sell
40,136
-8,048
-17% -$5.47M 0.1% 195
2025
Q3
$27.1M Buy
48,184
+6,405
+15% +$3.62M 0.09% 195
2025
Q2
$21.9M Buy
41,779
+4,894
+13% +$2.73M 0.08% 223
2025
Q1
$23.4M Sell
36,885
-315
-0.8% -$217K 0.09% 205
2024
Q4
$26.5M Sell
37,200
-1,661
-4% -$1.39M 0.1% 190
2024
Q3
$40.9M Sell
38,861
-4,046
-9% -$4.5M 0.14% 132
2024
Q2
$45.1M Sell
42,907
-2,339
-5% -$2.27M 0.17% 112
2024
Q1
$43.5M Sell
45,246
-3,018
-6% -$2.87M 0.16% 116
2023
Q4
$42.4M Sell
48,264
-2,154
-4% -$1.77M 0.17% 118
2023
Q3
$41.5M Buy
50,418
+21,990
+77% +$17.3M 0.17% 109
2023
Q2
$20.4M Sell
28,428
-834
-3% -$643K 0.09% 214
2023
Q1
$24M Buy
29,262
+1,899
+7% +$1.43M 0.11% 196
2022
Q4
$19.7M Sell
27,363
-1,295
-5% -$956K 0.09% 225
2022
Q3
$19.7M Buy
28,658
+255
+0.9% +$160K 0.1% 217
2022
Q2
$16.8M Buy
28,403
+1,014
+4% +$659K 0.08% 244
2022
Q1
$19.1M Sell
27,389
-2,423
-8% -$1.53M 0.07% 238
2021
Q4
$18.8M Sell
29,812
-69,978
-70% -$43M 0.07% 246
2021
Q3
$60.4M Buy
99,790
+18,478
+23% +$11.5M 0.24% 102
2021
Q2
$45.4M Sell
81,312
-16,071
-17% -$8.14M 0.17% 133
2021
Q1
$46.1M Buy
97,383
+78,564
+417% +$38.3M 0.19% 126
2020
Q4
$9.09M Sell
18,819
-10,464
-36% -$5.65M 0.04% 340
2020
Q3
$16.4M Sell
29,283
-1,496
-5% -$907K 0.08% 233
2020
Q2
$19.2M Buy
30,779
+4,932
+19% +$2.8M 0.09% 204
2020
Q1
$12.6M Buy
25,847
+6,817
+36% +$2.81M 0.07% 234
2019
Q4
$7.14M Sell
19,030
-801
-4% -$269K 0.03% 402
2019
Q3
$5.5M Buy
19,831
+1,710
+9% +$506K 0.03% 500
2019
Q2
$5.67M Sell
18,121
-8,485
-32% -$2.82M 0.03% 474
2019
Q1
$10.9M Sell
26,606
-37,807
-59% -$15.6M 0.05% 314
2018
Q4
$24.1M Buy
64,413
+2,217
+4% +$811K 0.13% 179
2018
Q3
$25.1M Buy
62,196
+43,654
+235% +$16.6M 0.12% 192
2018
Q2
$6.4M Hold
18,542
0.03% 446
2018
Q1
$6.38M Sell
18,542
-4,152
-18% -$1.44M 0.03% 480
2017
Q4
$8.53M Sell
22,694
-19,539
-46% -$7.91M 0.04% 408
2017
Q3
$18.9M Sell
42,233
-23,302
-36% -$11.1M 0.1% 225
2017
Q2
$32.2M Buy
65,535
+44,759
+215% +$19.6M 0.15% 158
2017
Q1
$8.05M Sell
20,776
-24,758
-54% -$9.18M 0.04% 409
2016
Q4
$16.7M Buy
45,534
+11,520
+34% +$4.38M 0.09% 233
2016
Q3
$13.7M Sell
34,014
-39,271
-54% -$15.8M 0.07% 302
2016
Q2
$25.6M Buy
73,285
+46,285
+171% +$17.8M 0.13% 182
2016
Q1
$9.73M Sell
27,000
-7,640
-22% -$3.15M 0.06% 328
2015
Q4
$18.8M Sell
34,640
-12,625
-27% -$6.84M 0.11% 200
2015
Q3
$22M Sell
47,265
-6,573
-12% -$3.53M 0.14% 182
2015
Q2
$27.5M Buy
53,838
+997
+2% +$487K 0.15% 164
2015
Q1
$23.9M Sell
52,841
-70,296
-57% -$29.8M 0.13% 187
2014
Q4
$50.5M Buy
123,137
+73,701
+149% +$29M 0.27% 96
2014
Q3
$17.8M Buy
49,436
+36,036
+269% +$12.1M 0.1% 215
2014
Q2
$3.79M Sell
13,400
-100
-0.7% -$29.6K 0.02% 535
2014
Q1
$4.05M Buy
13,500
+200
+2% +$61.6K 0.02% 512
2013
Q4
$3.66M Sell
13,300
-200
-1% -$57.5K 0.02% 591
2013
Q3
$4.22M Buy
+13,500
New +$3.55M 0.03% 552

Other funds holding REGN

State of Tennessee, Department of Treasury's REGN Position: Q1 2026 in Review

State of Tennessee, Department of Treasury increased its Regeneron Pharmaceuticals (REGN) stake by 3.3% in Q1 2026, buying an estimated $1.01M and bringing the position to 41,458 shares worth $32M. The position accounts for 0.11% of the portfolio, ranked #179.

State of Tennessee, Department of Treasury first reported a position in REGN in Q3 2013 and has held it in 51 quarters since. The position peaked at $60.4M in Q3 2021. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • State of Tennessee, Department of Treasury held 41,458 shares of Regeneron Pharmaceuticals worth $32M as of Q1 2026.
  • State of Tennessee, Department of Treasury bought 1,322 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $1.01M.
  • Regeneron Pharmaceuticals made up 0.11% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #179 holding.
  • State of Tennessee, Department of Treasury first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 51 quarters since.
  • State of Tennessee, Department of Treasury's Regeneron Pharmaceuticals position peaked at $60.4M in Q3 2021.
  • 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.